Immune-Oncology Market is Anticipated to Rise at a Significant CAGR Owing to Increase in R&D to Develop Anti-Cancer Drugs Till 2022: Radiant Insights, Inc.

SAN FRANCISCO, April 2, 2019 /PRNewswire/ --The global immune-oncology market is anticipated to rise at a significant CAGR in the forecast period. Immune-oncology market is driven by factors such as manufacturers' emphasis on upgrading immune-oncology drugs as well as increase in R&D to...

from PR Newswire: https://ift.tt/2uCUYze